[Multiple sclerosis: immunomodulators, education, and self-injection].
One hundred and sixty four patients of the Poitou-Charentes area suffering from multiple sclerosis (MS) and treated with an immunomodulating agent for more than 3 months completed a self-administered questionnaire. More than 60p.cent of the patients performed self-injection. For both modes of injection studied (subcutaneous or intramuscular), self-injection was significantly more frequent among patients who were received training and followed via telephone assistance conducted by a nurse with specialized training in MS. Our study demonstrated that waste disposal (needles), especially among patients performing self-injections, remains an important problem. Efforts must be taken concerning this important healthcare issue.
Moinot
N
N
Service de Neurologie, CHU La Milétrie, Poitiers.
Anne
O
O
Devoize
J-L
JL
Artaut-Uriot
M S
MS
Aubert-Cetou
I
I
Boissonnot
L
L
Debras
C
C
Lebras
F
F
Loll
P-Y
PY
Godeneche
G
G
Mesnage
V
V
Neau
J-P
JP
D000293:Adolescent; D000328:Adult; D000368:Aged; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000008:administration & dosage* / Q000627:therapeutic use*; D007273:Injections, Intramuscular; D007279:Injections, Subcutaneous; D008297:Male; D017744:Medical Waste Disposal; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000523:psychology / Q000628:therapy*; D009339:Needles; D009726:Nurses; D010353:Patient Education as Topic; D012646:Self Administration; D011795:Surveys and Questionnaires; D013689:Telephone
D007155:Immunologic Factors; D017744:Medical Waste Disposal